Home/Filings/4/0000905148-25-000963
4//SEC Filing

Sandoval David I. 4

Accession 0000905148-25-000963

CIK 0001287098other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 8:49 PM ET

Size

7.2 KB

Accession

0000905148-25-000963

Insider Transaction Report

Form 4
Period: 2025-03-14
Sandoval David I.
GENERAL COUNSEL
Transactions
  • Award

    Common Stock

    2025-03-14+23,12564,572 total
  • Award

    Employee Stock Option (right to buy)

    2025-03-14+92,50092,500 total
    Exercise: $3.29Exp: 2035-03-13Common Stock (92,500 underlying)
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 14, 2026, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
  • [F2]Twenty-five percent (25%) of the shares underlying this option shall vest on March 14, 2026, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file

Issuer

MAXCYTE, INC.

CIK 0001287098

Entity typeother

Related Parties

1
  • filerCIK 0002012430

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 8:49 PM ET
Size
7.2 KB